Raymond James Maintains Strong Buy on InflaRx, Lowers Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Steven Seedhouse has maintained a 'Strong Buy' rating on InflaRx (NASDAQ:IFRX), but lowered the price target from $21 to $19.
November 02, 2023 | 4:24 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Despite a lowered price target, InflaRx maintains a 'Strong Buy' rating from Raymond James, indicating continued confidence in the company's potential.
The lowered price target might initially seem negative, but the maintained 'Strong Buy' rating indicates that Raymond James still sees significant potential in InflaRx. This could lead to a neutral short-term impact on the stock as investors weigh the lowered price target against the continued confidence from the analyst.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100